Alibaba Health Information Technology (241.HK) Osake Kurssi
Alibaba Health Information Technology Kurssi
Liikevaihto on kasvanut 25,3 % vuodessa viimeisten 19 vuoden aikana 30,60 Mrd. CNY:een. Osakekohtainen tulos on kasvanut 20,0 % vuodessa viimeisten 19 vuoden aikana. Alibaba Health Information Technologyn nettomarginaali on nyt 4,7 %, noussut 2,2 %:sta muutama vuosi sitten. Analyytikoiden mediaanitavoitehinta on 5,21 CNY, eli yli nykyhintaa 128,8 %. 21 analyytikosta 13 suosittaa ostoa — kokonaiskonsensus on Osta.
Alibaba Health Information Technology osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Alibaba Health Information Technology liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Alibaba Health Information Technology -osakkeesta
The business model of Alibaba Health Information Technology Ltd focuses on providing online healthcare services in China. The company operates a comprehensive platform that connects users with healthcare professionals, offering a wide range of services including consultation appointments, medicine purchases, and health management tools. By leveraging Alibaba Group's technology and resources, Alibaba Health aims to improve accessibility and efficiency in the healthcare industry through their online platforms. Through partnerships with medical institutions, pharmaceutical companies, and insurance providers, Alibaba Health continues to expand their offerings, supporting the growth of digital healthcare in China.
Alibaba Health Information Technology Ltd is primarily active in the healthcare technology industry.
The main competitors of Alibaba Health Information Technology Ltd in the market are Ping An Good Doctor, JD Health International Inc., and Ping An Healthcare and Technology Company Limited.
Alibaba Health Information Technology Ltd, also known as Ali Health, is a prominent healthcare technology company in China. Founded in 2014, Ali Health is a subsidiary of Alibaba Group Holding Limited. The company focuses on integrating Internet technology with healthcare services to provide innovative solutions. Ali Health offers a wide range of services, including pharmaceutical e-commerce, online healthcare consultation, and health management platforms. With a mission to enhance the healthcare industry in China through digital transformation, Alibaba Health has become a leading player in the country's healthcare technology sector.
Alibaba Health Information Technology Ltd has achieved several significant milestones. One notable achievement is its listing on the Hong Kong Stock Exchange in 2014, symbolizing its growth and success in the market. Another milestone is the strategic partnership formed with Alibaba Group, a leading global technology company, which provides valuable resources and support for Alibaba Health's future development. Additionally, the company has expanded its healthcare services, including online healthcare consultation, medication e-commerce, and healthcare data analysis, allowing them to make a significant impact in the healthcare industry. These milestones demonstrate Alibaba Health Information Technology Ltd's commitment to innovation and its potential for future growth and success.
Alibaba Health Information Technology Ltd primarily operates in China.
Alibaba Health Information Technology Ltd represents a commitment to innovation and digital transformation in the healthcare industry. The company's values revolve around delivering high-quality healthcare services to individuals and promoting the development of a smarter healthcare ecosystem. With a focus on patient-centric solutions, Alibaba Health Information Technology Ltd aims to enhance accessibility, efficiency, and effectiveness in medical services through cutting-edge technologies. By leveraging Alibaba Group's extensive resources and expertise, the company strives to revolutionize healthcare delivery, empower patients, and improve overall health outcomes. Through its dedication to technological advancements and customer-centric approach, Alibaba Health Information Technology Ltd is poised to reshape the healthcare landscape in China and beyond.
Analyytikot asettavat tällä hetkellä Alibaba Health Information Technology-osakkeelle keskimääräisen tavoitehinnan 5,52 CNY (mediaani: 5,21 CNY), mikä merkitsee +142,5 % viimeisimpään hintaan verrattuna. Konsensus perustuu 21 analyytikkoarvioon.
Alibaba Health Information Technology Analyytikkojen kursstavoitteet 2026
21 analyytikkoa arvioi tällä hetkellä Alibaba Health Information Technology-osaketta: 13 suosittaa ostoa, 6 pitoa ja 2 myyntiä. Vuodelle 2026 analyytikot odottavat Alibaba Health Information Technology-yhtiöltä 35,59 Mrd. CNY liikevaihtoa ja 0,16 CNY osakekohtaista tulosta.
Alibaba Health Information Technology Analyytikkojen kursstavoitteet 2026
Nykyisellä valuuttakurssilla Alibaba Health Information Technology-osake noteerataan hintaan 0,31 EUR (2,28 CNY).
Alibaba Health Information Technology-osake (241.HK) on listattuna 8 pörssissä, muun muassa: SIX (Zürich) (TWY.SW), Hongkong (HKEX) (0241.HK), Frankfurt (TWY.F), München (TWY.MU), Stuttgart (TWY.SG), Düsseldorf (TWY.DU), Berlin (TWY.BE).
Alibaba Health Information Technology Ltd. is a company that offers health products and services. It is part of the Alibaba Group and is one of the largest providers of digital health services in China. The company's business model is based on three main divisions: e-commerce, digital health services, and pharmaceutical services. In e-commerce, Alibaba Health Information Technology Ltd. offers a wide range of health products, including supplements, vitamins, medical devices, and medical equipment. Products can be easily ordered through the company's online platform, with delivery usually taking place within a few days. In the field of digital health services, the company offers a comprehensive range of solutions to help customers improve their health and well-being. For example, there is an app that helps customers manage their health data and monitor their physical activity. In addition, there is an online diagnosis platform that allows users to quickly and easily identify their health problems. The company also provides pharmaceutical services, allowing patients to order their medications online and have them delivered directly to their homes, thus avoiding long wait times at pharmacies. The company also works closely with a number of health organizations and hospitals to offer its customers a comprehensive range of health services. These include telemedicine services, which allow patients to conduct medical consultations and examinations in real time. As part of its business model, Alibaba Health Information Technology Ltd. also operates a number of medical facilities, including traditional Chinese medicine clinics that offer a wide range of treatments. Overall, Alibaba Health Information Technology Ltd.'s business model is focused on improving healthcare in China. The company offers its customers a wide range of health products and services that allow users to conveniently and easily improve their health and well-being, while also making an important contribution to the digitization of healthcare.
odotettu liikevaihto Alibaba Health Information Technology on 35,59 Mrd. CNY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Alibaba Health Information Technology on 2,52 Mrd. CNY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Alibaba Health Information Technology:n hinta-voitto-suhde (P/E) on tällä hetkellä 14,57. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Alibaba Health Information Technology-osakkeen arvostusta.
Alibaba Health Information Technology:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,03. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Alibaba Health Information Technology-osakkeen arvostuskennuslukuna.
Alibaba Health Information Technology:n Eulpool-laatuscore on 6/10.
Alibaba Health Information Technology:n ISIN on BMG0171K1018. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Alibaba Health Information Technology:n WKN on A12EAP. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Alibaba Health Information Technology:n ticker on 241.HK. Tämä pörssinoteeraus käytetään Alibaba Health Information Technology-osakkeiden kauppaan pörssissä.
Alibaba Health Information Technology osake
Alibaba Health Information Technology vertaisryhmä
Alibaba Health Information Technology Ticker
Alibaba Health Information Technology FIGI
Kaikki tunnusluvut ja syvällinen analyysi Alibaba Health Information Technology:sta
Meidän osakeanalyysimme Alibaba Health Information Technology-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Alibaba Health Information Technology:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: